Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Eli, Eyal"'
Autor:
Tobias Winkler, Carsten Perka, Philipp vonRoth, Alison N. Agres, Henning Plage, Bernd Preininger, Matthias Pumberger, Sven Geissler, Esther Lukasiewicz Hagai, Racheli Ofir, Lena Pinzur, Eli Eyal, Gisela Stoltenburg‐Didinger, Christian Meisel, Christine Consentius, Mathias Streitz, Petra Reinke, Georg N. Duda, Hans‐Dieter Volk
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 9, Iss 5, Pp 880-897 (2018)
Abstract Background No regenerative approach has thus far been shown to be effective in skeletal muscle injuries, despite their high frequency and associated functional deficits. We sought to address surgical trauma‐related muscle injuries using lo
Externí odkaz:
https://doaj.org/article/a39b3ef4c8ba4bb799b90d26a06ddbe2
Autor:
Alison N. Agres, Tobias Winkler, Gisela Stoltenburg-Didinger, Henning Plage, Eli Eyal, Matthias Pumberger, Christian Meisel, Philipp von Roth, Mathias Streitz, Racheli Ofir, Sven Geissler, Esther Lukasiewicz Hagai, Christine Consentius, Carsten Perka, Lena Pinzur, Georg N. Duda, Hans-Dieter Volk, Bernd Preininger, Petra Reinke
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle. 9:880-897
Background No regenerative approach has thus far been shown to be effective in skeletal muscle injuries, despite their high frequency and associated functional deficits. We sought to address surgical trauma-related muscle injuries using local intraop
Autor:
Adagio investigators, Rom E. Eliaz, Arun K. Tiwari, Elijahu Berkovich, James L. Kennedy, Shannon Collinson, Iris Grossman, Maria Tampakeras, Cheryl Fitzer-Attas, Amir Tchelet, Jo Knight, Mario Masellis, Natalie Freeman, Anthony E. Lang, Victor Abler, Joseph Levy, Eli Eyal, Michael R. Hayden
Publikováno v:
Brain. 139:2050-2062
The treatment of early Parkinson's disease with dopaminergic agents remains the mainstay of symptomatic therapy for this incurable neurodegenerative disorder. However, clinical responses to dopaminergic drugs vary substantially from person to person
Publikováno v:
Basicclinical pharmacologytoxicology. 124(3)
As of March 2018, rasagiline is approved for the treatment of Parkinson disease in 55 countries including Japan. The present study evaluated the pharmacokinetics (PK) and safety of rasagiline in healthy Japanese and Caucasian subjects following singl
Autor:
Christian Meisel, Philipp von Roth, Alison N. Agres, Sven Geissler, Tobias Winkler, Gisela Stoltenburg-Didinger, Carsten Perka, Georg N. Duda, Matthias Pumberger, Racheli Ofir, Eli Eyal, Hans-Dieter Volk, Bernd Preininger, Lena Pinzur, Esther Lukasiewicz Hagai, Christine Consentius, Petra Reinke, Henning Plage, Mathias Streitz
BackgroundNo regenerative approach has thus far been shown to be effective in skeletal muscle injuries, despite high frequency and associated functional deficits. We sought to address surgical trauma related muscle injuries using local intraoperative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf6ac8368d120a62bbd508d1e8e9b29
https://doi.org/10.1101/297739
https://doi.org/10.1101/297739
Autor:
Julie C. Stout, Ralf Reilmann, M Grozinski-Wolff, Spyros Papapetropoulos, Karen E. Anderson, Sarah J. Tabrizi, Blair R. Leavitt, Michael R. Hayden, Paola Piccini, Andrew Feigin, Eli Eyal
Publikováno v:
Neurotherapeutics. 13:240-260
Autor:
Megan J, Shram, Orit, Cohen-Barak, Bijan, Chakraborty, Merav, Bassan, Kerri A, Schoedel, Hussein, Hallak, Eli, Eyal, Sivan, Weiss, Yossi, Gilgun-Serki, Yossi, Gilgun, Edward M, Sellers, Janice, Faulknor, Ofer, Spiegelstein
Publikováno v:
Journal of Clinical Psychopharmacology. 35:396-405
UNLABELLED Cocaine dependence presents a major public health issue, and to date, no pharmacotherapies are approved for its treatment. TV-1380 is a novel recombinant albumin-fused mutated butyrylcholinesterase (Albu-BChE) that has increased catalytic
Autor:
Anna Elgart, Eli Eyal, Joel Morganroth, Craig R Sprenger, Ofer Spiegelstein, Dorit Mimrod, Emil Samara, Laura Rabinovich
Publikováno v:
Clinical pharmacology in drug development. 8(1)
In this randomized double-blind study, 4 groups of healthy subjects (50 per arm) participated to evaluate the effect of laquinimod, an oral treatment in development for multiple sclerosis and Huntington disease, on the QTc interval. Subjects received
Publikováno v:
Movement Disorders. 29:1028-1034
Dopamine agonists (DA) are often used as first-line monotherapy for the symptomatic control of Parkinson's disease (PD). However, DA monotherapy typically becomes inadequate within a few years, at which time the DA dosage must be increased or other a